| Literature DB >> 32593681 |
M P Smirnova1, N I Kolodkin1, A A Kolobov3, V G Afonin1, I V Afonina1, L I Stefanenko1, V M Shpen'1, O V Shamova2, A A Kolobov3.
Abstract
To create a broad-spectrum peptide biocide, we synthesized 45 analogs of antimicrobial peptide indolicidin (H-Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH2). Among them the peptides H-Ile-Leu-Pro-(2-Me)Phe-Lys-(2-Me)Phe-Pro-(2-Me)Phe-(2-Me)Phe-Pro-(2-Me)Phe-Arg-Arg-NH2 and HN2-(CH2)10-Ile-Leu-Pro-D-Phe-Lys-D-Phe-Pro-D-Phe-D-Phe-Pro-D-Phe-Arg-Arg-NH2 have the broadest spectrum of antimicrobial activity and the lowest hemolytic activity. They are active against all 11 tested strains of Gram-positive bacteria, Gram-negative bacteria and fungi with MIC50 from 0.9 to 6.1 μg/ml (0.5 to 3.2 μM), being up to 3 times more active than indolicidin, and are at least 1.8 times less hemolytically active than indolicidin (reached the detection limit). These peptides are patented and could be used for further drug development as antimicrobials.Entities:
Keywords: AMP; Antimicrobial peptide; biocide; drug design; indolicidin; screening
Mesh:
Substances:
Year: 2020 PMID: 32593681 DOI: 10.1016/j.peptides.2020.170356
Source DB: PubMed Journal: Peptides ISSN: 0196-9781 Impact factor: 3.750